Instrument Inactif

Autres langues ECHO THERAPEUTICS OTC Bulletin Board

Actions

US27876L1070

Equipement et technologie médicale avancés

Cours en clôture OTC Bulletin Board Autres places de cotation
- ^USD	-

Autres langues

22/03/17	Echo Therapeutics, Inc. Appoints Alan W. Schoenbart as Chief Executive Officer
23/11/16	Echo Therapeutics, Inc. Appoints Alan W. Schoenbart as Interim Chief Executive Officer
27/09/16	Echo Therapeutics, Inc. Announces Resignation of Dr. Elazer Edelman as Member of the Board of Directors and Audit Committee
12/08/16	Echo Therapeutics, Inc. Announces Earnings Results for the Second Quarter Ended June 30, 2016
13/07/16	Echo Therapeutics, Inc.(OTCPK:ECTE) dropped from S&P TMI Index
12/07/16	Echo Therapeutics, Inc. Primary Exchange Listing will Change to OTCQB Marketplace from Nasdaq Capital Market
11/07/16	Echo Therapeutics, Inc.(NasdaqCM:ECTE) dropped from NASDAQ Composite Index
13/06/16	Echo Therapeutics, Inc. Announces Institutional Review Board Approval of New Protocol
10/06/16	Echo Therapeutics Seeks Acquisitions
26/05/16	Echo Therapeutics, Inc. Announces New Appointments
20/05/16	Echo Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2016
03/05/16	Echo Therapeutics, Inc. announced that it has received $4.47 million in funding.
30/03/16	Echo Therapeutics, Inc. Reports Consolidated Earnings Results for the Year Ended December 31, 2015
22/03/16	Echo Therapeutics Issues Promissory Note to Platinum Partners Value Arbitrage Fund
29/01/16	Echo Therapeutics, Inc. announced that it expects to receive $4.47 million in funding.
28/12/15	Echo Therapeutics, Inc. Appoints Elazer Edelman to its Board of Directors
16/11/15	Echo Therapeutics, Inc. Announces Earnings Results for the Third Quarter Ended September 30, 2015
24/09/15	Echo Therapeutics, Inc. announced that it expects to receive $0.32 million in funding from Beijing Yi Tang Bio Science & Technology, Ltd., Platinum Management (NY) LLC, and another investor.
27/08/15	Echo Therapeutics, Inc. announced that it expects to receive $0.15 million in funding from Platinum Management (NY) LLC and Beijing Yi Tang Bio Science & Technology, Ltd.
14/08/15	Echo Therapeutics, Inc. Announces Earnings Results for the Second Quarter Ended June 30, 2015
26/05/15	Worldwide Business with kathy ireland® Selects Echo Therapeutics, Inc. for Wearable Technology Feature
15/05/15	Echo Therapeutics, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015
16/04/15	Echo Therapeutics, Inc. Reports Consolidated Earnings Results for the Year Ended December 31, 2014
15/04/15	Echo Therapeutics, Inc. Reports Revised Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014
15/04/15	Echo Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt